3 Stocks to Keep an Eye on Ahead of Next Week's Earnings_老虎社区_美港股上老虎

3 Stocks to Keep an Eye on Ahead of Next Week's Earnings

Motley Fool2021-10-22

I'll discuss the three stocks I'll be watching ahead of next week's earnings: Facebook(FB), Twitter(TWTR), and Teladoc. Facebook Last quarter it was all about the metaverse and how Mark Zuckerberg ...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

JB0112
·2021-10-22
ok
回复
1
举报
FlorCheah
·2021-10-22
ER nx week
回复
1
举报
SFern
·2021-10-22
Good
回复
3
举报
收起
- SFern:
  Lol
  2021-10-22
  回复
  举报
stormlee
·2021-10-22
Ple like Thks
回复
2
举报
收起
- Tohyx:
  Tiger
  2021-10-22
  回复
  举报

热议股票

7x24

全部

关于我们·老虎社区守则·老虎社区账号管理规范·老虎社区服务协议·老虎社区隐私政策

公司名称：北京至简风宜信息技术有限公司

违法和不良信息投诉：010-5681-3562（工作时间9:30-18:30）

邮箱：service@laohu8.com

营业执照：91110105MA01A4U55R

ICP备：京ICP备18016422号

网安备：京公网安备11010502036490

关注我们

{"i18n":{"language":"zh_CN"},"data":{"share":"https://www.laohu8.com/m/news/2177497008?lang=zh_CN&edition=full","thumbnail":"","is_english":true,"pubTime":"2021-10-22 20:15","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2177497008","market":"us","top_or_hot":-1,"title":"3 Stocks to Keep an Eye on Ahead of Next Week's Earnings","media":"Motley Fool","content":"<div>\n<p>I'll discuss the three stocks I'll be watching ahead of next week's earnings: Facebook(FB), Twitter(TWTR), and Teladoc. \nFacebook\nLast quarter it was all about the metaverse and how Mark Zuckerberg ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/10/22/3-stocks-to-keep-an-eye-on-ahead-of-next-weeks-ear/\">网页链接</a>\n\n</div>\n","source":"fool_stock","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Stocks to Keep an Eye on Ahead of Next Week's Earnings</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Stocks to Keep an Eye on Ahead of Next Week's Earnings\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-10-22 20:15 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/10/22/3-stocks-to-keep-an-eye-on-ahead-of-next-weeks-ear/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>I'll discuss the three stocks I'll be watching ahead of next week's earnings: Facebook(FB), Twitter(TWTR), and Teladoc. \nFacebook\nLast quarter it was all about the metaverse and how Mark Zuckerberg ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/10/22/3-stocks-to-keep-an-eye-on-ahead-of-next-weeks-ear/\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"TWTR","symbol_name":"Twitter","start_time":0,"source_url":"https://www.fool.com/investing/2021/10/22/3-stocks-to-keep-an-eye-on-ahead-of-next-weeks-ear/","article_id":"2177497008","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2177497008","pubTimestamp":1634904901,"sourceInfo":{"source_id":"fool_stock","name":"Motley Fool"},"weMediaInfo":null,"summary":"I'll discuss the three stocks I'll be watching ahead of next week's earnings: Facebook(FB), Twitter(","collect":0,"end_time":0,"defaultTopTitle":"fool.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"TWTR":"Twitter","TDOC":"Teladoc Health Inc."},"translate_title":"下周财报发布前需关注的3只股票","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"FB":0.9,"TDOC":0.9,"TWTR":0.9},"content_text":"I'll discuss the three stocks I'll be watching ahead of next week's earnings: Facebook(FB), Twitter(TWTR), and Teladoc. \nFacebook\nLast quarter it was all about the metaverse and how Mark Zuckerberg wants Facebook to become a metaverse company and not just a social media.One Rumor circulated this week that Facebook is looking to change its name, and may be taking a page out of Google's playbook when it changed its name to Alphabet back in 2015.\nLast quarter Facebook was very careful with its outlook because of the year-over-year comps and ad targeting changes, mainly from iOS. So it will be interesting to see how big the impact was. And lastly, shareholders might want to get an update on the whole whistleblower situation. The resulting dip was in my opinion an opportunity to buy Facebook at a discount.\nTwitter\nJust like with Facebook and Snap, Twitter's results will give me better insight into social media ad spending. Since I'm a holder of Pinterest (unless PayPal(PYPL) acquires it), that will be crucial info. Besides that, I'm curious to know how the new features on Twitter are doing. The last time we got some numbers regarding Super Follows, those weren't great. In the first two weeks of the launch, it generated just $6,000. The advertising targeting on Twitter is horrible compared to other platforms, so I'm curious to see how well the company has performed this quarter. Total revenue is expected to be between $1.22 billion and $1.3 billion.\nTeladoc\nAs I wrote at the start of the month, a broken stock does not equal a broken company. I think it's about time the market stopped seeing Teladoc as just a COVID-19 play but as a major revolutionary upgrade to the current state of healthcare. Despite the stock being down 30% year to date, the company continues to grow each and every quarter. The company expects to grow revenue 78%, and total visits 23% year over year at the midpoint.","kind":null,"is_publish_news":true,"is_publish_highlight":true,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":851215189,"gmtCreate":1634910484486,"gmtModify":1634910485570,"author":{"id":"3585877031221506","authorId":"3585877031221506","name":"JB0112","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3585877031221506","authorIdStr":"3585877031221506"},"htmlText":"ok","listText":"ok","text":"ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/851215189","repostId":2177497008,"repostType":4,"repost":{"id":"2177497008","pubTimestamp":1634904901,"share":"https://www.laohu8.com/m/news/2177497008?lang=&edition=full","pubTime":"2021-10-22 20:15","market":"us","language":"en","title":"3 Stocks to Keep an Eye on Ahead of Next Week's Earnings","url":"https://stock-news.laohu8.com/highlight/detail?id=2177497008","media":"Motley Fool","summary":"I'll discuss the three stocks I'll be watching ahead of next week's earnings: Facebook(FB), Twitter(","content":"<p> I'll discuss the three stocks I'll be watching ahead of next week's earnings: <b>Facebook(FB)</b>, <b>Twitter(TWTR)</b>, and <b>Teladoc</b>. </p>\n<h2>Facebook</h2>\n<p>Last quarter it was all about the metaverse and how Mark Zuckerberg wants Facebook to become a metaverse company and not just a social media.One Rumor circulated this week that Facebook is looking to change its name, and may be taking a page out of Google's playbook when it changed its name to <b>Alphabet</b> back in 2015.</p>\n<p>Last quarter Facebook was very careful with its outlook because of the year-over-year comps and ad targeting changes, mainly from iOS. So it will be interesting to see how big the impact was. And lastly, shareholders might want to get an update on the whole whistleblower situation. The resulting dip was in my opinion an opportunity to buy Facebook at a discount.</p>\n<h2>Twitter</h2>\n<p>Just like with Facebook and <b>Snap</b>, Twitter's results will give me better insight into social media ad spending. Since I'm a holder of <b>Pinterest</b> (unless <b>PayPal(PYPL)</b> acquires it), that will be crucial info.&nbsp;Besides that, I'm curious to know how the new features on Twitter are doing. The last time we got some numbers regarding Super Follows, those weren't great. In the first two weeks of the launch, it generated just $6,000. The advertising targeting on Twitter is horrible compared to other platforms, so I'm curious to see how well the company has performed this quarter. Total revenue is expected to be between $1.22 billion and $1.3 billion.</p>\n<h2>Teladoc</h2>\n<p>As I wrote at the start of the month, a broken stock does not equal a broken company. I think it's about time the market stopped seeing Teladoc as just a COVID-19 play but as a major revolutionary upgrade to the current state of healthcare. Despite the stock being down 30% year to date, the company continues to grow each and every quarter. The company expects to grow revenue 78%, and total visits 23% year over year at the midpoint.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Stocks to Keep an Eye on Ahead of Next Week's Earnings</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Stocks to Keep an Eye on Ahead of Next Week's Earnings\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-10-22 20:15 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/10/22/3-stocks-to-keep-an-eye-on-ahead-of-next-weeks-ear/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>I'll discuss the three stocks I'll be watching ahead of next week's earnings: Facebook(FB), Twitter(TWTR), and Teladoc. \nFacebook\nLast quarter it was all about the metaverse and how Mark Zuckerberg ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/10/22/3-stocks-to-keep-an-eye-on-ahead-of-next-weeks-ear/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TDOC":"Teladoc Health Inc.","TWTR":"Twitter"},"source_url":"https://www.fool.com/investing/2021/10/22/3-stocks-to-keep-an-eye-on-ahead-of-next-weeks-ear/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2177497008","content_text":"I'll discuss the three stocks I'll be watching ahead of next week's earnings: Facebook(FB), Twitter(TWTR), and Teladoc. \nFacebook\nLast quarter it was all about the metaverse and how Mark Zuckerberg wants Facebook to become a metaverse company and not just a social media.One Rumor circulated this week that Facebook is looking to change its name, and may be taking a page out of Google's playbook when it changed its name to Alphabet back in 2015.\nLast quarter Facebook was very careful with its outlook because of the year-over-year comps and ad targeting changes, mainly from iOS. So it will be interesting to see how big the impact was. And lastly, shareholders might want to get an update on the whole whistleblower situation. The resulting dip was in my opinion an opportunity to buy Facebook at a discount.\nTwitter\nJust like with Facebook and Snap, Twitter's results will give me better insight into social media ad spending. Since I'm a holder of Pinterest (unless PayPal(PYPL) acquires it), that will be crucial info. Besides that, I'm curious to know how the new features on Twitter are doing. The last time we got some numbers regarding Super Follows, those weren't great. In the first two weeks of the launch, it generated just $6,000. The advertising targeting on Twitter is horrible compared to other platforms, so I'm curious to see how well the company has performed this quarter. Total revenue is expected to be between $1.22 billion and $1.3 billion.\nTeladoc\nAs I wrote at the start of the month, a broken stock does not equal a broken company. I think it's about time the market stopped seeing Teladoc as just a COVID-19 play but as a major revolutionary upgrade to the current state of healthcare. Despite the stock being down 30% year to date, the company continues to grow each and every quarter. The company expects to grow revenue 78%, and total visits 23% year over year at the midpoint.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":851678365,"gmtCreate":1634908444462,"gmtModify":1634908678502,"author":{"id":"3573025586175142","authorId":"3573025586175142","name":"FlorCheah","avatar":"https://static.tigerbbs.com/8cb91e5f44e414335718e1beffda39e8","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3573025586175142","authorIdStr":"3573025586175142"},"htmlText":"ER nx week","listText":"ER nx week","text":"ER nx week","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/851678365","repostId":2177497008,"repostType":4,"repost":{"id":"2177497008","pubTimestamp":1634904901,"share":"https://www.laohu8.com/m/news/2177497008?lang=&edition=full","pubTime":"2021-10-22 20:15","market":"us","language":"en","title":"3 Stocks to Keep an Eye on Ahead of Next Week's Earnings","url":"https://stock-news.laohu8.com/highlight/detail?id=2177497008","media":"Motley Fool","summary":"I'll discuss the three stocks I'll be watching ahead of next week's earnings: Facebook(FB), Twitter(","content":"<p> I'll discuss the three stocks I'll be watching ahead of next week's earnings: <b>Facebook(FB)</b>, <b>Twitter(TWTR)</b>, and <b>Teladoc</b>. </p>\n<h2>Facebook</h2>\n<p>Last quarter it was all about the metaverse and how Mark Zuckerberg wants Facebook to become a metaverse company and not just a social media.One Rumor circulated this week that Facebook is looking to change its name, and may be taking a page out of Google's playbook when it changed its name to <b>Alphabet</b> back in 2015.</p>\n<p>Last quarter Facebook was very careful with its outlook because of the year-over-year comps and ad targeting changes, mainly from iOS. So it will be interesting to see how big the impact was. And lastly, shareholders might want to get an update on the whole whistleblower situation. The resulting dip was in my opinion an opportunity to buy Facebook at a discount.</p>\n<h2>Twitter</h2>\n<p>Just like with Facebook and <b>Snap</b>, Twitter's results will give me better insight into social media ad spending. Since I'm a holder of <b>Pinterest</b> (unless <b>PayPal(PYPL)</b> acquires it), that will be crucial info.&nbsp;Besides that, I'm curious to know how the new features on Twitter are doing. The last time we got some numbers regarding Super Follows, those weren't great. In the first two weeks of the launch, it generated just $6,000. The advertising targeting on Twitter is horrible compared to other platforms, so I'm curious to see how well the company has performed this quarter. Total revenue is expected to be between $1.22 billion and $1.3 billion.</p>\n<h2>Teladoc</h2>\n<p>As I wrote at the start of the month, a broken stock does not equal a broken company. I think it's about time the market stopped seeing Teladoc as just a COVID-19 play but as a major revolutionary upgrade to the current state of healthcare. Despite the stock being down 30% year to date, the company continues to grow each and every quarter. The company expects to grow revenue 78%, and total visits 23% year over year at the midpoint.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Stocks to Keep an Eye on Ahead of Next Week's Earnings</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Stocks to Keep an Eye on Ahead of Next Week's Earnings\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-10-22 20:15 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/10/22/3-stocks-to-keep-an-eye-on-ahead-of-next-weeks-ear/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>I'll discuss the three stocks I'll be watching ahead of next week's earnings: Facebook(FB), Twitter(TWTR), and Teladoc. \nFacebook\nLast quarter it was all about the metaverse and how Mark Zuckerberg ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/10/22/3-stocks-to-keep-an-eye-on-ahead-of-next-weeks-ear/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TDOC":"Teladoc Health Inc.","TWTR":"Twitter"},"source_url":"https://www.fool.com/investing/2021/10/22/3-stocks-to-keep-an-eye-on-ahead-of-next-weeks-ear/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2177497008","content_text":"I'll discuss the three stocks I'll be watching ahead of next week's earnings: Facebook(FB), Twitter(TWTR), and Teladoc. \nFacebook\nLast quarter it was all about the metaverse and how Mark Zuckerberg wants Facebook to become a metaverse company and not just a social media.One Rumor circulated this week that Facebook is looking to change its name, and may be taking a page out of Google's playbook when it changed its name to Alphabet back in 2015.\nLast quarter Facebook was very careful with its outlook because of the year-over-year comps and ad targeting changes, mainly from iOS. So it will be interesting to see how big the impact was. And lastly, shareholders might want to get an update on the whole whistleblower situation. The resulting dip was in my opinion an opportunity to buy Facebook at a discount.\nTwitter\nJust like with Facebook and Snap, Twitter's results will give me better insight into social media ad spending. Since I'm a holder of Pinterest (unless PayPal(PYPL) acquires it), that will be crucial info. Besides that, I'm curious to know how the new features on Twitter are doing. The last time we got some numbers regarding Super Follows, those weren't great. In the first two weeks of the launch, it generated just $6,000. The advertising targeting on Twitter is horrible compared to other platforms, so I'm curious to see how well the company has performed this quarter. Total revenue is expected to be between $1.22 billion and $1.3 billion.\nTeladoc\nAs I wrote at the start of the month, a broken stock does not equal a broken company. I think it's about time the market stopped seeing Teladoc as just a COVID-19 play but as a major revolutionary upgrade to the current state of healthcare. Despite the stock being down 30% year to date, the company continues to grow each and every quarter. The company expects to grow revenue 78%, and total visits 23% year over year at the midpoint.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":851626536,"gmtCreate":1634905835325,"gmtModify":1634905911016,"author":{"id":"3582938826092533","authorId":"3582938826092533","name":"SFern","avatar":"https://static.tigerbbs.com/81a61c88544234a53cc63054a8f769b1","vip":1,"crmLevel":1,"crmLevelSwitch":0,"idStr":"3582938826092533","authorIdStr":"3582938826092533"},"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/851626536","repostId":2177497008,"repostType":4,"repost":{"id":"2177497008","pubTimestamp":1634904901,"share":"https://www.laohu8.com/m/news/2177497008?lang=&edition=full","pubTime":"2021-10-22 20:15","market":"us","language":"en","title":"3 Stocks to Keep an Eye on Ahead of Next Week's Earnings","url":"https://stock-news.laohu8.com/highlight/detail?id=2177497008","media":"Motley Fool","summary":"I'll discuss the three stocks I'll be watching ahead of next week's earnings: Facebook(FB), Twitter(","content":"<p> I'll discuss the three stocks I'll be watching ahead of next week's earnings: <b>Facebook(FB)</b>, <b>Twitter(TWTR)</b>, and <b>Teladoc</b>. </p>\n<h2>Facebook</h2>\n<p>Last quarter it was all about the metaverse and how Mark Zuckerberg wants Facebook to become a metaverse company and not just a social media.One Rumor circulated this week that Facebook is looking to change its name, and may be taking a page out of Google's playbook when it changed its name to <b>Alphabet</b> back in 2015.</p>\n<p>Last quarter Facebook was very careful with its outlook because of the year-over-year comps and ad targeting changes, mainly from iOS. So it will be interesting to see how big the impact was. And lastly, shareholders might want to get an update on the whole whistleblower situation. The resulting dip was in my opinion an opportunity to buy Facebook at a discount.</p>\n<h2>Twitter</h2>\n<p>Just like with Facebook and <b>Snap</b>, Twitter's results will give me better insight into social media ad spending. Since I'm a holder of <b>Pinterest</b> (unless <b>PayPal(PYPL)</b> acquires it), that will be crucial info.&nbsp;Besides that, I'm curious to know how the new features on Twitter are doing. The last time we got some numbers regarding Super Follows, those weren't great. In the first two weeks of the launch, it generated just $6,000. The advertising targeting on Twitter is horrible compared to other platforms, so I'm curious to see how well the company has performed this quarter. Total revenue is expected to be between $1.22 billion and $1.3 billion.</p>\n<h2>Teladoc</h2>\n<p>As I wrote at the start of the month, a broken stock does not equal a broken company. I think it's about time the market stopped seeing Teladoc as just a COVID-19 play but as a major revolutionary upgrade to the current state of healthcare. Despite the stock being down 30% year to date, the company continues to grow each and every quarter. The company expects to grow revenue 78%, and total visits 23% year over year at the midpoint.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Stocks to Keep an Eye on Ahead of Next Week's Earnings</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Stocks to Keep an Eye on Ahead of Next Week's Earnings\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-10-22 20:15 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/10/22/3-stocks-to-keep-an-eye-on-ahead-of-next-weeks-ear/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>I'll discuss the three stocks I'll be watching ahead of next week's earnings: Facebook(FB), Twitter(TWTR), and Teladoc. \nFacebook\nLast quarter it was all about the metaverse and how Mark Zuckerberg ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/10/22/3-stocks-to-keep-an-eye-on-ahead-of-next-weeks-ear/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TDOC":"Teladoc Health Inc.","TWTR":"Twitter"},"source_url":"https://www.fool.com/investing/2021/10/22/3-stocks-to-keep-an-eye-on-ahead-of-next-weeks-ear/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2177497008","content_text":"I'll discuss the three stocks I'll be watching ahead of next week's earnings: Facebook(FB), Twitter(TWTR), and Teladoc. \nFacebook\nLast quarter it was all about the metaverse and how Mark Zuckerberg wants Facebook to become a metaverse company and not just a social media.One Rumor circulated this week that Facebook is looking to change its name, and may be taking a page out of Google's playbook when it changed its name to Alphabet back in 2015.\nLast quarter Facebook was very careful with its outlook because of the year-over-year comps and ad targeting changes, mainly from iOS. So it will be interesting to see how big the impact was. And lastly, shareholders might want to get an update on the whole whistleblower situation. The resulting dip was in my opinion an opportunity to buy Facebook at a discount.\nTwitter\nJust like with Facebook and Snap, Twitter's results will give me better insight into social media ad spending. Since I'm a holder of Pinterest (unless PayPal(PYPL) acquires it), that will be crucial info. Besides that, I'm curious to know how the new features on Twitter are doing. The last time we got some numbers regarding Super Follows, those weren't great. In the first two weeks of the launch, it generated just $6,000. The advertising targeting on Twitter is horrible compared to other platforms, so I'm curious to see how well the company has performed this quarter. Total revenue is expected to be between $1.22 billion and $1.3 billion.\nTeladoc\nAs I wrote at the start of the month, a broken stock does not equal a broken company. I think it's about time the market stopped seeing Teladoc as just a COVID-19 play but as a major revolutionary upgrade to the current state of healthcare. Despite the stock being down 30% year to date, the company continues to grow each and every quarter. The company expects to grow revenue 78%, and total visits 23% year over year at the midpoint.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":6289122,"gmtCreate":1634905840609,"gmtModify":1634905840643,"authorId":3582938826092533,"author":{"id":3582938826092533,"idStr":"3582938826092533","authorId":3582938826092533,"name":"SFern","avatar":"https://static.tigerbbs.com/81a61c88544234a53cc63054a8f769b1","vip":1,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":851626536,"type":1,"supId":0,"prevId":0,"content":"Lol","text":"Lol","html":"Lol"}],"langContent":"CN"},{"id":851623983,"gmtCreate":1634905433663,"gmtModify":1634905435638,"author":{"id":"3571959390768435","authorId":"3571959390768435","name":"stormlee","avatar":"https://static.tigerbbs.com/80629ef9648273c0d6465aee66dbd98a","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3571959390768435","authorIdStr":"3571959390768435"},"htmlText":"Ple like Thks","listText":"Ple like Thks","text":"Ple like Thks","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/851623983","repostId":2177497008,"repostType":4,"repost":{"id":"2177497008","pubTimestamp":1634904901,"share":"https://www.laohu8.com/m/news/2177497008?lang=&edition=full","pubTime":"2021-10-22 20:15","market":"us","language":"en","title":"3 Stocks to Keep an Eye on Ahead of Next Week's Earnings","url":"https://stock-news.laohu8.com/highlight/detail?id=2177497008","media":"Motley Fool","summary":"I'll discuss the three stocks I'll be watching ahead of next week's earnings: Facebook(FB), Twitter(","content":"<p> I'll discuss the three stocks I'll be watching ahead of next week's earnings: <b>Facebook(FB)</b>, <b>Twitter(TWTR)</b>, and <b>Teladoc</b>. </p>\n<h2>Facebook</h2>\n<p>Last quarter it was all about the metaverse and how Mark Zuckerberg wants Facebook to become a metaverse company and not just a social media.One Rumor circulated this week that Facebook is looking to change its name, and may be taking a page out of Google's playbook when it changed its name to <b>Alphabet</b> back in 2015.</p>\n<p>Last quarter Facebook was very careful with its outlook because of the year-over-year comps and ad targeting changes, mainly from iOS. So it will be interesting to see how big the impact was. And lastly, shareholders might want to get an update on the whole whistleblower situation. The resulting dip was in my opinion an opportunity to buy Facebook at a discount.</p>\n<h2>Twitter</h2>\n<p>Just like with Facebook and <b>Snap</b>, Twitter's results will give me better insight into social media ad spending. Since I'm a holder of <b>Pinterest</b> (unless <b>PayPal(PYPL)</b> acquires it), that will be crucial info.&nbsp;Besides that, I'm curious to know how the new features on Twitter are doing. The last time we got some numbers regarding Super Follows, those weren't great. In the first two weeks of the launch, it generated just $6,000. The advertising targeting on Twitter is horrible compared to other platforms, so I'm curious to see how well the company has performed this quarter. Total revenue is expected to be between $1.22 billion and $1.3 billion.</p>\n<h2>Teladoc</h2>\n<p>As I wrote at the start of the month, a broken stock does not equal a broken company. I think it's about time the market stopped seeing Teladoc as just a COVID-19 play but as a major revolutionary upgrade to the current state of healthcare. Despite the stock being down 30% year to date, the company continues to grow each and every quarter. The company expects to grow revenue 78%, and total visits 23% year over year at the midpoint.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Stocks to Keep an Eye on Ahead of Next Week's Earnings</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Stocks to Keep an Eye on Ahead of Next Week's Earnings\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-10-22 20:15 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/10/22/3-stocks-to-keep-an-eye-on-ahead-of-next-weeks-ear/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>I'll discuss the three stocks I'll be watching ahead of next week's earnings: Facebook(FB), Twitter(TWTR), and Teladoc. \nFacebook\nLast quarter it was all about the metaverse and how Mark Zuckerberg ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/10/22/3-stocks-to-keep-an-eye-on-ahead-of-next-weeks-ear/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TDOC":"Teladoc Health Inc.","TWTR":"Twitter"},"source_url":"https://www.fool.com/investing/2021/10/22/3-stocks-to-keep-an-eye-on-ahead-of-next-weeks-ear/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2177497008","content_text":"I'll discuss the three stocks I'll be watching ahead of next week's earnings: Facebook(FB), Twitter(TWTR), and Teladoc. \nFacebook\nLast quarter it was all about the metaverse and how Mark Zuckerberg wants Facebook to become a metaverse company and not just a social media.One Rumor circulated this week that Facebook is looking to change its name, and may be taking a page out of Google's playbook when it changed its name to Alphabet back in 2015.\nLast quarter Facebook was very careful with its outlook because of the year-over-year comps and ad targeting changes, mainly from iOS. So it will be interesting to see how big the impact was. And lastly, shareholders might want to get an update on the whole whistleblower situation. The resulting dip was in my opinion an opportunity to buy Facebook at a discount.\nTwitter\nJust like with Facebook and Snap, Twitter's results will give me better insight into social media ad spending. Since I'm a holder of Pinterest (unless PayPal(PYPL) acquires it), that will be crucial info. Besides that, I'm curious to know how the new features on Twitter are doing. The last time we got some numbers regarding Super Follows, those weren't great. In the first two weeks of the launch, it generated just $6,000. The advertising targeting on Twitter is horrible compared to other platforms, so I'm curious to see how well the company has performed this quarter. Total revenue is expected to be between $1.22 billion and $1.3 billion.\nTeladoc\nAs I wrote at the start of the month, a broken stock does not equal a broken company. I think it's about time the market stopped seeing Teladoc as just a COVID-19 play but as a major revolutionary upgrade to the current state of healthcare. Despite the stock being down 30% year to date, the company continues to grow each and every quarter. The company expects to grow revenue 78%, and total visits 23% year over year at the midpoint.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":6289506,"gmtCreate":1634908401401,"gmtModify":1634953504590,"authorId":3577615424644075,"author":{"id":3577615424644075,"idStr":"3577615424644075","authorId":3577615424644075,"name":"Tohyx","avatar":"https://static.tigerbbs.com/09925fd9e75b6221e2e1ebab3f7bff4e","vip":1,"crmLevel":5,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":851623983,"type":1,"supId":0,"prevId":0,"content":"Tiger","text":"Tiger","html":"Tiger"}],"langContent":"CN"}],"hasMoreComments":true,"newsSizeData":{"likeSize":42,"commentSize":4,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false}}